CD4 and COVID-19: The presence of anti-lymphocyte antibodies (ALAb) might play an important role in disease outcome, and more specifically in the lymphopenia observed in most COVID-19 patients, characterized by low numbers of CD4, CD8, and, to a lesser extent, B cells (21, 22).